Search company, investor...

Predict your next investment

InterVest company logo
Venture Capital
FINANCE | Investment Firms & Funds
intervest.co.kr

Investments

127

Portfolio Exits

9

Funds

2

About InterVest

InterVest is a venture capital firm that specializes in startups and early stage businesses, providing pre-initial public offering financing through mezzanine and bridge transactions. It typically invests in biotechnology, healthcare, semiconductor, display, metal and non-metal, energy, machinery, nanotechnology, telecommunications equipment and services, wireless communication terminal-related hardware, computer, software and applications and digital content sectors in Korea.

Headquarters Location

#1701 Trade Tower 511, Yeongdong-daero, Gangnam-gu

Seoul, 06164,

South Korea

+82-2-551-7340

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest InterVest News

Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification

Nov 29, 2023

(marketscreener.com) Dear Madam, Sir, Please find hereunder the links to Intervest Offices & Warehouses’ latest press release regarding the publication of a transparency notification. Geachte mevrouw, meneer, Gelieve hierbij de links te vinden naar het recente persbericht van Intervest Offices & Warehouses betreffende de openbaarmaking over...https://www.marketscreener.com/quote/stock/INTERVEST-OFFICES-WAREHOU-9426804/news/Intervest-Offices-Warehouses-NV-Press-release-ndash-Persbericht-ndash-Communique-de-presse-p-45464629/?utm_medium=RSS&utm_content=20231129

InterVest Investments

127 Investments

InterVest has made 127 investments. Their latest investment was in Oncocross as part of their Unattributed VC on November 11, 2023.

CBI Logo

InterVest Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/13/2023

Unattributed VC

Oncocross

$10.95M

Yes

3

11/8/2023

Seed VC

mogul

$3.6M

Yes

2

11/7/2023

Series B

MEZOO

$13.75M

No

3

11/6/2023

Series B

Subscribe to see more

$99M

Subscribe to see more

10

10/26/2023

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/13/2023

11/8/2023

11/7/2023

11/6/2023

10/26/2023

Round

Unattributed VC

Seed VC

Series B

Series B

Series B

Company

Oncocross

mogul

MEZOO

Subscribe to see more

Subscribe to see more

Amount

$10.95M

$3.6M

$13.75M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

2

3

10

10

InterVest Portfolio Exits

9 Portfolio Exits

InterVest has 9 portfolio exits. Their latest portfolio exit was Lunit on July 21, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/21/2022

IPO

$99M

Public

2

7/19/2022

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

12/21/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

8/4/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

12/25/2019

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/21/2022

7/19/2022

12/21/2020

8/4/2020

12/25/2019

Exit

IPO

Acquired

IPO

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

InterVest Fund History

2 Fund Histories

InterVest has 2 funds, including InterVest Star Southeast Asia Growth Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/5/2017

InterVest Star Southeast Asia Growth Fund I

Multi-Stage Venture Capital

Open

$60M

1

8/14/2013

Global Pharmaceutical Fund

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/5/2017

8/14/2013

Fund

InterVest Star Southeast Asia Growth Fund I

Global Pharmaceutical Fund

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Status

Open

Subscribe to see more

Amount

$60M

$99M

Sources

1

10

InterVest Team

2 Team Members

InterVest has 2 team members, including current Chief Executive Officer, President, Tae-Yong Lee.

Name

Work History

Title

Status

Tae-Yong Lee

Chief Executive Officer, President

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Tae-Yong Lee

Subscribe to see more

Work History

Title

Chief Executive Officer, President

Subscribe to see more

Status

Current

Subscribe to see more

Compare InterVest to Competitors

General Catalyst Logo
General Catalyst

General Catalyst is a venture capital firm that makes early-stage and transformational investments. It back entrepreneurs who are building technology companies and businesses, and invests in seed-stage, early-stage, later-stage, and growth-stage companies operating in consumer, enterprise, fintech, crypto, health assurance, software, transportation, big data, and technology sectors. The company was founded in 2000 and is based in Cambridge, Massachusetts.

SyndicateRoom Logo
SyndicateRoom

SyndicateRoom is an online equity crowdfunding platform that allows its members to co-invest in exciting companies with seasoned investors.

L
Lightspeed Venture Partners

Lightspeed Venture Partners operates as an early-stage venture capital firm. It focuses on accelerating disruptive innovations and trends in the enterprise and consumer sectors. It was founded in 2000 and is based in Menlo Park, California.

R
Revolution

Revolution is a venture capital firm. It makes seed, early-stage, and growth equity investments. It was founded in 2005 and is based in Washington, DC.

D
DealBench

DealBench is an early-stage investor. It invests in early-stage companies in the global Internet, consumer, and financial technology industries. It was founded in 2002 and is based in Houston, Texas. It was acquired by Atlas Acquisitions, Inc. in 2003.

Sequoia Capital Logo
Sequoia Capital

Sequoia is a venture capital firm. It seeks to invest in companies operating in the information technology, healthcare, manufacturing, mobile, nanotechnology, financial service, internet, energy, media, and retail sectors. The company was founded in 1972 and is based in Menlo Park, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.